Web Toolbar by Wibiya
Login | Sign Up AnonymousUser
twiter
New to Comunitee?


or Sign Up with Email

Health

>> MELANOMA Latest News

SEP 30, 2014 - Huffington Post

A Must Read - Share

New Cancer Drugs Have Fewer Side Effects -- But Worryingly High Price Tags

By Ben Hirschler MADRID, Sept 30 (Reuters) - A raft of new cancer drugs promise better, longer-lasting treatments with fewer adverse side effects -- but their high cost is a growing concern. Drugs that help the body's own immune cells fight tumors are expected to be used in multi-drug cocktails, pushing the price of therapies costing more than $100,000 a ...

Tags: New Cancer Drugs Have Fewer Side Effects -- But Worryingly High Price Tags,  Melanoma Latest News

SEP 30, 2014 - Health Canal

A Must Read - Share

New cancer drug combination halts disease, extends life in advanced melanoma patients

A world-first study in today's New England Journal of Medicine heralds the efficacy of a targeted combination drug therapy after reporting major declines in the risk of disease progression and death in people with metastatic melanoma.

Tags: New cancer drug combination halts disease, extends life in advanced melanoma patients,  Melanoma Latest News

SEP 30, 2014 - Seattle Times

A Must Read - Share

Promising new approaches offer hope for melanoma patients

The Pacific Northwest has some of the highest rates of melanoma in the nation. So it’s not surprising that Seattle’s Fred Hutchinson Cancer Research Center is pioneering promising new treatments for the deadly cancer.

Tags: Promising new approaches offer hope for melanoma patients,  Melanoma Latest News

SEP 29, 2014 - MedPage Today

A Must Read - Share

Targeted Drugs Build on Efficacy Record in Melanoma (CME/CE)

MADRID (MedPage Today) -- Studies called a "death knell" for conventional chemotherapy in advanced melanoma.

Tags: Targeted Drugs Build on Efficacy Record in Melanoma (CME/CE),  Melanoma Latest News

SEP 29, 2014 - Reuters

A Must Read - Share

Roche, GSK melanoma pill combinations look similar in showdown

MADRID (Reuters) - Rival two-pill combinations for melanoma from Roche and GlaxoSmithKline had similarly good results in separate clinical trials, leaving doctors with little to choose between the two skin cancer courses.

Tags: Roche, GSK melanoma pill combinations look similar in showdown,  Melanoma Latest News